Human Bromodomain containing 2, also known as BRD2, RING3 or RNF3, GenBank Accession No. NM_005104, a.a. 65 – 187 corresponding to bromodomain 2 with N-terminal GST-tag, MW = 41.4 kDa, expressed in an E. coli expression system.

P25440

BRD2, RING, RNF3, Bromodomain containing 2

Assay was performed using BRD2 BD2 Inhibitor Screening Assay Kit, Cat. #32522. BRD2 protein is incubated with biotinylated acetyl-histone peptide substrate (Cat. #33000) in BRD assay buffer (Cat. #33001) in a 10 µl reaction for 1 hour at RT. AlphaLISA^® ® GSH acceptor beads (PerkinElmer) are added, followed by Alphascreen^®® Streptavidin-conjugated donor beads (PerkinElmer). After 1 hour incubation at RT, Alphacounts are measured.

50 mM Tris-HCl, pH 8.0, 138 mM NaCl, 2.7 mM KCl, 10% glycerol, 3 mM EDTA, 20 mM glutathione, and 2 mM DTT

Aqueous buffer solution

>6 months at –80°C.

Useful for the study of bromodomain binding assays, screening inhibitors, and selectivity profiling.

1. Umehara, T., et al., FEBS Lett. 2010 Sep 24; 584(18): 3901-3908.
2. Shang, E., et al., J Cell Biochem. 2011 Oct; 112(10): 2784-2793.

Avoid freeze/thaw cycles.

Bromodomain

Recombinant Protein